E
Empee Sugars & Chemicals
500132 BSE
Empee Sugars & Chemicals
Fast Moving Consumer Goods BSE: 500132 Agricultural Food & other Products
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Weaknesses
1- Company has low interest coverage ratio.
Growth Rate
Net Income Growth
39% higher than
3Y
Quarterly Results
| Particulars | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 4 | 36 | 7 | 24 | 33 | 20 | 1 | 0 | 9 | 5 | 0 | 1 | 0 |
| Expenses | 7 | 57 | 8 | 23 | 33 | 31 | 3 | 2 | 9 | 16 | 4 | 13 | 8 |
| Operating Profit | -3 | -21 | -1 | 1 | -1 | -11 | -2 | -2 | 0 | -12 | -3 | -13 | -8 |
| OPM % | -78% | -60% | -11% | 2.8% | -1.6% | -58% | -215% | -1736% | 5% | -237% | -821% | -2024% | — |
| Other Income | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 4 | 0 | 0 |
| Interest | 20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 6 | 6 | 6 | 6 | 6 | 6 | 6 | -3 | 2 | 2 | 2 | 2 | 2 |
| PBT | -28 | -26 | -7 | -5 | -7 | -18 | -8 | 1 | -1 | -13 | -1 | -14 | -10 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Profit | -28 | -26 | -7 | -5 | -7 | -18 | -8 | 1 | -1 | -13 | -1 | -14 | -10 |
| EPS in Rs | -6.74 | -6.15 | -1.64 | -1.29 | -1.58 | -4.28 | -2 | 0.19 | -0.3 | -3.02 | -0.25 | -3.35 | -2.41 |
Profit & Loss
| Particulars | Mar 2010 | Sep 2011 18m | Mar 2013 18m | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Feb 2022 11m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 45.82 | 399 | 391 | 280 | 125 | 50.45 | 82.94 | 15.23 | 2.05 | 0 | 0 | 0 |
| Expenses | 36.71 | 331 | 337 | 269 | 276 | 78.75 | 95.02 | 30.35 | 8.39 | 2.81 | 1.71 | 0.02 |
| Operating Profit | 9.11 | 67.78 | 53.21 | 10.66 | -151 | -28.3 | -12.08 | -15.12 | -6.34 | -2.81 | -1.71 | -0.02 |
| OPM % | 19.88% | 16.98% | 13.63% | 3.81% | -120.43% | -56.1% | -14.56% | -99.28% | -309.27% | — | — | — |
| Other Income | 0.3 | 6.31 | 1.17 | 6.28 | 6.83 | 2.51 | 0.44 | 0.58 | 0.51 | 0.01 | 0.01 | 0.01 |
| Interest | 5.28 | 96.35 | 76.74 | 63.76 | 70.82 | 56.87 | 0.46 | 0 | 3.24 | 0 | 0 | 0 |
| Depreciation | 3.54 | 34.45 | 31.08 | 20.71 | 25.18 | 24.74 | 7.72 | 7.03 | 6.82 | 6.64 | 6.47 | 5.71 |
| PBT | 0.59 | -56.71 | -53.44 | -67.53 | -240 | -107 | -19.82 | -21.57 | -15.89 | -9.44 | -8.17 | -5.72 |
| Tax % | -57.63% | -32.02% | -33.55% | -19.18% | 20.72% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Profit | 0.93 | -38.55 | -35.51 | -54.58 | -290 | -107 | -19.82 | -21.56 | -15.89 | -9.44 | -8.18 | -5.72 |
| EPS in Rs | 0.22 | -9.18 | -8.46 | -13 | -69.09 | -25.59 | -4.72 | -5.14 | -3.79 | -2.25 | -1.95 | -1.36 |
| Div. Payout % | 0% | -5.44% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
| Particulars | Mar 2010 | Sep 2011 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Feb 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 41.97 | 41.97 | 41.97 | 41.97 | 41.97 | 41.97 | 41.97 | 41.97 | 41.97 | 41.97 | 41.97 | 41.97 |
| Reserves | 118 | 71.08 | 39.49 | -13.6 | -313 | -419 | -396 | -413 | -424 | -429 | -432 | -434 |
| Borrowings | 389 | 529 | 559 | 563 | 709 | 764 | 763 | 762 | 771 | 772 | 772 | 772 |
| Other Liabilities | 37.15 | 44.52 | 130 | 126 | 33.75 | 32.16 | 42.85 | 48.95 | 48.64 | 48.47 | 48.49 | 48.49 |
| Total Liabilities | 586 | 686 | 771 | 717 | 471 | 419 | 452 | 440 | 437 | 433 | 430 | 429 |
| Fixed Assets | 51.08 | 392 | 362 | 354 | 320 | 311 | 370 | 361 | 355 | 348 | 341 | 336 |
| CWIP | 302 | 5.74 | 11.34 | 0 | 15.57 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 23.28 | 23.28 | 23.29 | 9.61 | 15.96 | 10.91 | 6.67 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 210 | 265 | 375 | 353 | 120 | 97.41 | 75.82 | 78.67 | 82.38 | 85.52 | 88.99 | 92.75 |
| Total Assets | 586 | 686 | 771 | 717 | 471 | 419 | 452 | 440 | 437 | 433 | 430 | 429 |
Cash Flow
| Particulars | Mar 2010 | Sep 2011 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Feb 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 2.16 | -11.73 | 46.65 | 75.57 | -78.25 | 0.32 | 2.82 | 0 | -2.64 | -0.07 | 0 | 0 |
| Investing | -324 | -31.34 | -5.42 | -1.29 | -1.7 | 0.06 | -0.05 | 0 | 0 | 0 | 0 | 0 |
| Financing | 315 | 41.53 | -33.28 | -81.69 | 79.77 | -0.95 | -1.74 | 0 | 3.23 | 0 | 0 | 0 |
| Net Cash Flow | -6.97 | -1.54 | 7.95 | -7.41 | -0.17 | -0.56 | 1.03 | 0 | 0.59 | -0.07 | 0 | 0 |
| Free Cash Flow | -322 | -43.69 | 40.92 | 73.52 | -80.32 | 0.32 | 2.74 | 0 | -2.64 | -0.07 | 0 | 0 |
| CFO/OP | 25 | -17 | 88 | 709 | 52 | -1 | -23 | 0 | 42 | 2 | 0 | 0 |
Ratios
| Particulars | Mar 2010 | Sep 2011 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Feb 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 21.59 | 61.29 | 125 | 127 | 21.51 | 7.09 | 1.76 | 21.09 | 157 | — | — | — |
| Inventory Days | 393 | 145 | 141 | 189 | 25.49 | 62.6 | 41.43 | 327 | 6,227 | — | — | — |
| Days Payable | 398 | 37.84 | 139 | 177 | 40.17 | 115 | 158 | 955 | 18,290 | — | — | — |
| Cash Conversion Cycle | 16.2 | 168 | 126 | 138 | 6.83 | -45.1 | -115 | -607 | -11,906 | — | — | — |
| Working Capital Days | 876 | -21.79 | 21.64 | -2.1 | -633 | -1,882 | -1,198 | -6,640 | -50,204 | — | — | — |
| ROCE % | 1.51% | 6.73% | 3.64% | -1.41% | -32.94% | -12.26% | -4.86% | -5.39% | -3.25% | -2.44% | -2.13% | -1.5% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Empee Sugars & Chemicals insights
56 extracted metrics + investor summaries across FY08–FY21.
Documents
1
Corporate Insolvency Resolution Process (CIRP)-Liquidation - Corporate Insolvency Resolution Process (CIRP)
2 Mar 2023 - In accordance with the requirements of sub-clause 16(f) of Clause A of Part A of Schedule III of Listing Regulations, I would like to inform … 2 Mar 2023 - In accordance with the requirements of sub-clause 16(f) of Clause A of Part A of Schedule III of Listing Regulations, I would like to inform …
2
Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP) 28 Jan 2023
Result
3
Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP) 28 Jan 2023
Result
Frequently Asked Questions about Empee Sugars & Chemicals
What does Empee Sugars & Chemicals Ltd do?
Empee Sugars and Chemicals Ltd is an Indian based company specializes in Sugar business.
Where is Empee Sugars & Chemicals Ltd (EMPEESUG) listed?
Empee Sugars & Chemicals Ltd trades under code 500132 on the BSE.
Which sector does Empee Sugars & Chemicals Ltd belong to?
Empee Sugars & Chemicals Ltd is classified under the Fast Moving Consumer Goods sector, in the Agricultural Food & other Products industry.
Company Information
Empee Sugars and Chemicals Ltd is an Indian based company specializes in Sugar business.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/EMPEESUG.md for Empee Sugars & Chemicals Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.